Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cubist Pharmaceuticals Inc (CBST)    
$55.49 0.54 (0.96%) as of 4:30 Fri 5/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 64,403,000 as of 9/30
Market Cap: 3.57(B)
Last Volume: 633,786 Avg Vol: 946,669
52 Week Range: $37.79 - $56.11
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Cubist Pharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. Co. has two marketed products, CUBICIN® (daptomycin for injection) and ENTEREG® (alvimopan). CUBICIN is a once-daily, bactericidal, intravenous antibiotic with activity against methicillin-resistant Staphylococcus aureus. CUBICIN is approved for the treatment of certain Gram-positive bacteria and for certain bloodstream infections. ENTEREG is approved to accelerate upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis.
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 6,500
Total Buy Value $0 $0 $0 $241,877
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 186,881 316,738 463,374 977,611
Total Sell Value $9,324,717 $14,896,456 $21,368,565 $41,823,728
Total People Sold 9 9 13 14
Total Sell Transactions 26 34 47 74
End Date 2013-02-24 2012-11-23 2012-05-25 2011-05-26

   
Records found: 536
  Page 1 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Singleton J Matthew Director   •       •      –    2013-05-22 4 OE $9.56 $493,025 D/D 27,500 31,125     -
   Singleton J Matthew Director   •       •      –    2013-05-22 4 S $55.48 $1,525,755 D/D (27,500) 3,625 0%     
   Bonney Michael W Chief Executive Officer   •       •      –    2013-05-20 4 AS $50.00 $3,000,006 D/D (60,000) 161,518     -
   Laranjeira Charles Anthony SVP, Technical Operations   •       •      –    2013-05-20 4 OE $35.90 $511,885 D/D 14,000 15,257     -
   Laranjeira Charles Anthony SVP, Technical Operations   •       •      –    2013-05-20 4 AS $50.00 $720,000 D/D (14,000) 1,257     -
   Bonney Michael W Chief Executive Officer   •       •      –    2013-05-20 4 OE $12.61 $756,600 D/D 60,000 221,518     -
   Stea Gregory SVP, Commercial Operations   •       •      –    2013-05-20 4 OE $16.76 $73,325 D/D 4,375 18,564     -
   Stea Gregory SVP, Commercial Operations   •       •      –    2013-05-20 4 AS $50.00 $218,750 D/D (4,375) 14,189     -
   Perez Robert J President & COO   •       •      –    2013-05-20 4 OE $10.35 $155,250 D/D 15,000 50,945     -
   Perez Robert J President & COO   •       •      –    2013-05-20 4 AS $49.98 $749,700 D/D (15,000) 35,945     -
   Stea Gregory SVP, Commercial Operations   •       •      –    2013-05-16 4 AS $47.88 $12,831 D/D (268) 14,189     -
   Perez Robert J President & COO   •       •      –    2013-05-16 4 AS $47.88 $71,814 D/D (1,500) 35,945     -
   Gilman Steven C EVP & Chief Scientific Officer   •       •      –    2013-05-16 4 AS $48.88 $58,700 D/D (1,201) 23,507     -
   Bonney Michael W Chief Executive Officer   •       •      –    2013-05-16 4 AS $47.88 $114,902 D/D (2,400) 161,518     -
   Gilman Steven C EVP & Chief Scientific Officer   •       •      –    2013-05-15 4 AS $48.41 $49,238 D/D (1,017) 22,208 0%     
   Stea Gregory SVP, Commercial Operations   •       •      –    2013-05-15 4 AS $48.41 $28,758 D/D (594) 13,657 0%     
   Perez Robert J President & COO   •       •      –    2013-05-15 4 AS $48.41 $72,138 D/D (1,490) 34,320 0%     
   Bonney Michael W Chief Executive Officer   •       •      –    2013-05-15 4 AS $48.41 $144,227 D/D (2,979) 158,918 0%     
   Bate Kenneth Director   •       •      –    2013-05-15 4 OE $11.89 $29,725 D/D 2,500 8,339     -
   Bate Kenneth Director   •       •      –    2013-05-15 4 AS $48.41 $121,025 D/D (2,500) 5,839 0%     
   Gilman Steven C EVP & Chief Scientific Officer   •       •      –    2013-05-15 4 OE $0.00 $0 D/D 2,500 24,708     -
   Bonney Michael W Chief Executive Officer   •       •      –    2013-05-15 4 OE $0.00 $0 D/D 5,000 163,918     -
   Stea Gregory SVP, Commercial Operations   •       •      –    2013-05-15 4 OE $0.00 $0 D/D 800 14,457     -
   Perez Robert J President & COO   •       •      –    2013-05-15 4 OE $0.00 $0 D/D 3,125 37,445     -
   Gilman Steven C EVP & Chief Scientific Officer   •       •      –    2013-05-14 4 AS $49.18 $55,818 D/D (1,135) 20,725 -0%     
  536 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2010 J3SG.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us